Literature DB >> 1639355

Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats.

T Ikeda1, K Yanaga, K Kishikawa, S Kakizoe, M Shimada, K Sugimachi.   

Abstract

Using liver allografts with warm or cold ischemia, we evaluated functional and morphological alterations in hepatocytes, sinusoidal endothelial cells and Kupffer cells in a rat transplantation model. All recipients of allografts with either 4 hr of cold or 30 min of warm ischemia lived more than 22 days and were judged viable. On the other hand, all recipients of grafts with 6 hr of cold or 60 min of warm ischemia died within 2 days and were therefore judged to be nonviable. With these viable and nonviable allograft models, hepatocyte function was evaluated by the bile output and serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvic transaminase and serum lactate dehydrogenase levels; endothelial cell function was judged by the serum hyaluronic acid level, and Kupffer cell function was measured by an intravenous colloidal carbon clearance test. Hepatocyte injury was the prominent feature in warm ischemic grafts, especially in the nonviable ones. On the other hand, serum hyaluronic acid values were significantly higher in the nonviable cold ischemic group, compared with the viable counterpart, suggesting that the functional depression of endothelial cells was predominant in cold, nonviable livers. Histological examinations coincided with the above findings. The phagocytic activity of Kupffer cells was depressed by warm or cold ischemia, whereas the number of Kupffer cells was reduced in the warm ischemia group. We conclude that in liver allografts the main site of injury in warm ischemia is the hepatocytes and suggest that cold ischemia is associated with endothelial cell damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639355     DOI: 10.1002/hep.1840160226

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  47 in total

1.  Can the rat donor liver tolerate prolonged warm ischemia?

Authors:  Ji-Qi Yan; Hong-Wei Li; Wei-Yao Cai; Ming-Jun Zhang; Wei-Ping Yang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

3.  Caspase inhibition in liver transplantation: from basic research to clinical studies.

Authors:  Raffaele Cursio
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

Review 4.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

5.  Effects of preoperative statin on liver reperfusion injury in major hepatic resection: a pilot study.

Authors:  Shashwat Sarin; Lileswar Kaman; Divya Dahiya; Arunanshu Behera; Bikash Medhi; Yogesh Chawla
Journal:  Updates Surg       Date:  2016-05-10

Review 6.  Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

Authors:  Yuan Zhai; Henrik Petrowsky; Johnny C Hong; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

7.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

8.  Upregulation of TLR2/4 expression in mononuclear cells in postoperative systemic inflammatory response syndrome after liver transplantation.

Authors:  Ziqing Hei; Xinjin Chi; Nan Cheng; Gangjian Luo; Shangrong Li
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

Review 9.  TLR2 and TLR4 in ischemia reperfusion injury.

Authors:  F Arslan; B Keogh; P McGuirk; A E Parker
Journal:  Mediators Inflamm       Date:  2010-06-09       Impact factor: 4.711

10.  Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.

Authors:  G Zöhrens; T Armbrust; K H Meyer Zum Büschenfelde; G Ramadori
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.